Certara (CERT) President Robert Aspbury Receives Awards

What Happened
Robert Aspbury, President (Predictive Tech) of Certara, reported multiple equity awards on May 11, 2026. The Form 4 shows a disposition to the issuer of 68,348 previously granted performance stock units (PSUs) (treated as cancelled/amended) and four award transactions acquiring a total of 531,309 derivative units (PSUs and restricted stock units). All awards are reported at $0.00 purchase price (standard for grants); no immediate cash transaction or open-market purchase/sale occurred.

Key Details

• Transaction date(s): May 11, 2026; Form 4 filed May 13, 2026 (timely filing).
• Reported disposition: 68,348 old PSUs to issuer (F1) — effectively amended/cancelled.
• Reported acquisitions (all awards, $0.00 price): 68,348; 86,419; 246,913; 129,629 — total acquired = 531,309 derivative units.
• Award types and footnotes:
  • F1: Amendment of PSUs originally granted May 20, 2025 (each PSU = conditional right to one share; amended PSUs pay 0%–200% of target based on performance through Mar 31, 2028). The amendment may be treated as cancellation of old PSUs and issuance of new PSUs.
  • F2: 246,913 RSUs granted May 11, 2026; each vests/settles in three equal installments on Apr 1, 2027, Apr 1, 2028, and Apr 1, 2029 (or cash equivalent).
  • F3: 86,419 and 129,629 PSUs granted May 11, 2026 (total 216,048); each PSU vests based on total shareholder return performance through Mar 31, 2029 and may pay between 0%–200% of target.
• Reported price/value: $0.00 per unit; no cash proceeds.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: Filed within the standard Form 4 timeframe (filed 2 days after the transaction date).

Context
These entries are award grants and an amendment of prior performance awards (derivative transactions), not open-market buys or sales. PSUs are performance-based and may ultimately convert to 0–200% of the target shares depending on future TSR results and vesting; RSUs vest on time-based schedules. Such awards are routine compensation for executives and do not, by themselves, indicate a personal purchase or sale of stock.